drugset / Trial / NCT05733286
REPOSE Study: Reducing Delirium by Enhancing Postoperative Sleep With Suvorexant
RandomizedParallel-groupTriple-blindTreatment
Summary
This research study will evaluate the effectiveness of postoperative administration of a drug called suvorexant, to improve postoperative sleep and decrease the severity of delirium (serious confusion) in adults 65 years and older undergoing non-cardiac surgery.
Timeline
- Start
- 2023-06-28
- Primary completion
- 2025-06-25
- Completion
- 2025-07-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Suvorexant | Small molecule | 20 mg | Oral |